Haleon (LON:HLN) Now Covered by HSBC

HSBC initiated coverage on shares of Haleon (LON:HLN) in a report released on Thursday, MarketBeat.com reports. The firm issued a buy rating on the stock.

Separately, Barclays dropped their target price on shares of Haleon from GBX 390 ($4.85) to GBX 383 ($4.77) and set an overweight rating for the company in a report on Tuesday, April 9th.

Haleon Stock Up 1.0 %

Shares of LON HLN opened at GBX 324.30 ($4.04) on Thursday. The company has a 50 day simple moving average of GBX 324.27 and a 200-day simple moving average of GBX 326.79. The company has a market capitalization of £29.61 billion and a P/E ratio of 2,920.00. The company has a debt-to-equity ratio of 57.42, a current ratio of 1.04 and a quick ratio of 0.93. Haleon has a 1 year low of GBX 306.80 ($3.82) and a 1 year high of GBX 357.65 ($4.45).

Haleon Increases Dividend

The firm also recently declared a dividend, which will be paid on Thursday, May 16th. Shareholders of record on Thursday, March 14th will be given a GBX 4.20 ($0.05) dividend. This represents a yield of 1.34%. The ex-dividend date is Thursday, March 14th. This is a boost from Haleon’s previous dividend of $1.80. Haleon’s dividend payout ratio (DPR) is currently 5,454.55%.

Insider Buying and Selling at Haleon

In other Haleon news, insider Tobias Hestler sold 23,564 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of GBX 329 ($4.10), for a total value of £77,525.56 ($96,508.85). 22.53% of the stock is currently owned by corporate insiders.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.